Resources

Type of publications
Regions
Diseases
3850 results found
2021 ∙ McMillan, M. Chandrakumar, A. Wang, H. L. R. Clarke, M. Sullivan, T. R. Andrews, R. M. Ramsay, M. Marshall, H. S.
Effectiveness of Meningococcal Vaccines at Reducing Invasive Meningococcal Disease and Pharyngeal Neisseria meningitidis Carriage: A Systematic Review and Meta-analysis
All age groups Meningococcal disease Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2021 ∙ Wang, Y. Li, J. Dai, P. Liu, P. Zhu, F.
Effectiveness of the oral human attenuated pentavalent rotavirus vaccine (RotaTeq™) postlicensure: a meta-analysis—2006–2020
Newborn Children Rotavirus Efficacy/effectiveness Administration Coverage
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Yedlapati, S. H. Khan, S. U. Talluri, S. Lone, A. N. Khan, M. Z. Khan, M. S. Navar, A. M. Gulati, M. Johnson, H. Baum, S. Michos, E. D.
Effects of Influenza Vaccine on Mortality and Cardiovascular Outcomes in Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis
Adults Influenza Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Harder, T. Koch, J. Vygen-Bonnet, S. Külper-Schiek, W. Pilic, A. Reda, S. Scholz, S. Wichmann, O.
Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021
All age groups COVID-19 Efficacy/effectiveness Safety
Methodological quality (AMSTAR 2):
Low
2021 ∙ Xing, K. Tu, X. Y. Liu, M. Liang, Z. W. Chen, J. N. Li, J. J. Jiang, L. G. Xing, F. Q. Jiang, Y.
Efficacy and safety of COVID-19 vaccines: a systematic review
Adults COVID-19 Efficacy/effectiveness Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Zizza, A. Banchelli, F. Guido, M. Marotta, C. Di Gennaro, F. Mazzucco, W. Pistotti, V. D'Amico, R.
Efficacy and safety of human papillomavirus vaccination in HIV-infected patients: a systematic review and meta-analysis
Adults Human papillomavirus (HPV) Efficacy/effectiveness Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Beckham, S. W. Crossnohere, N. L. Gross, M. Bridges, J. F. P.
Eliciting Preferences for HIV Prevention Technologies: A Systematic Review
All age groups HIV / AIDS Acceptance Coverage
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Campbell, J. Sutherland, J. Bucknall, D. O’hara, L. Heywood, A. Hobbs, M. Ballantyne, A. Gray, L.
Equity in vaccine trials for higher weight people? A rapid review of weight-related inclusion and exclusion criteria for COVID-19 clinical trials
Adults Older adults COVID-19 Coverage Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Wu, Q. Dudley, M. Z. Chen, X. Bai, X. Dong, K. Zhuang, T. Salmon, D. Yu, H.
Evaluation of the safety profile of COVID-19 vaccines: a rapid review
Children Adolescents Adults Older adults COVID-19 Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...